3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Sarcoma, Alveolar Soft Part
1
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
1
Muscle-invasive Bladder Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
enzalutamide
2
apalutamide
2
Pluvicto
2
Leuprolide
2
Androgen Antagonists
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
relugolix
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
luprolide acetate gel depot
1
larotrectinib
1
ipatasertib
1
gallium 68 PSMA-11
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Prostatic Neoplasms
×
atezolizumab
×
Clear all
No trials found.